Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01077882
What this trial is testing

Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
University Hospital, Ghent 50
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Not applicableActive Not RecruitingNCT07244744
What this trial is testing

Tilrdakizumab Almirall

Who this might be right for
Psoriasis
University Hospital Schleswig-Holstein 3
Post-approval studies (Phase 4)Study completedNCT00655564
What this trial is testing

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

Who this might be right for
Psoriasis
Wake Forest University 15
Post-approval studies (Phase 4)UnknownNCT03478280
What this trial is testing

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Aarhus University Hospital 50
Not applicableStudy completedNCT05959070
What this trial is testing

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

Who this might be right for
Psoriasis
AbbVie 154
Testing effectiveness (Phase 2)Study completedNCT01901705
What this trial is testing

Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
China Medical University Hospital 24
Post-approval studies (Phase 4)Study completedNCT06333860
What this trial is testing

Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Who this might be right for
Moderate Plaque Psoriasis
AbbVie 393
Not applicableEnrolling By InvitationNCT03254667
What this trial is testing

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 3,500
Post-approval studies (Phase 4)Study completedNCT04229836
What this trial is testing

Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 178
Large-scale testing (Phase 3)Study completedNCT05108766
What this trial is testing

A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis

Who this might be right for
Plaque Psoriasis
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Testing effectiveness (Phase 2)Looking for participantsNCT07801495
What this trial is testing

Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Moderate to Severe Psoriatic Arthritis
Novartis Pharmaceuticals 220
Large-scale testing (Phase 3)Study completedNCT07712705
What this trial is testing

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

Who this might be right for
Psoriasis
Newsoara Biopharma Co., Ltd. 515
Testing effectiveness (Phase 2)Study completedNCT05858047
What this trial is testing

An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

Who this might be right for
Effects, Drug Side
CSPC Ouyi Pharmaceutical Co., Ltd. 93
Large-scale testing (Phase 3)Study completedNCT02748863
What this trial is testing

Study of Secukinumab With 2 mL Pre-filled Syringes

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 214
Large-scale testing (Phase 3)Study completedNCT01186744
What this trial is testing

Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 666
Testing effectiveness (Phase 2)Study completedNCT02852967
What this trial is testing

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Kadmon Corporation, LLC 110
Testing effectiveness (Phase 2)Study completedNCT02762994
What this trial is testing

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 120
Large-scale testing (Phase 3)Study completedNCT00096603
What this trial is testing

Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Who this might be right for
Psoriasis
Genentech, Inc. 450
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation